RE:RE:Currency Impact on Q3I personnally expect a little 9$ after the approval not more because TH is TH. TH Investors seems not willing to speculate much with TH stock. Then all will depend how good sales are reported in the first reports. As we know, TH invested in a big sales team. They did it because they trust the drug and because they expect results. They had a lot of time to train the team, I guess they put in place a good marketting strategy so I cant see how they cant penetrate the market at a decent level. I am hoping for a 11$ SP after TH manage to provide first numbers about Ibalizumab's sales. In the mean time, lets hope our pathetic world leaders dont mess with the planet !!